Write your message
Volume 6, Issue 3 (Summer 2021)                   J Obstet Gynecol Cancer Res 2021, 6(3): 152-156 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Golshahi F, Shirazi M, Rahimi Sharbaf F, Zarkesh M R, Nahavandi N. A Case Report of Complete Resolution of Nonimmunological Hydrops Fetalis Without Known Etiology. J Obstet Gynecol Cancer Res. 2021; 6 (3) :152-156
URL: http://jogcr.com/article-1-320-en.html
1- Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Yas Hospital, Tehran, Iran
2- Department of Neonatology, Yas Women Hospital, Tehran University of Medical Sciences, Tehran, Iran
3- Shahid Akbarabadi Hospital, Iran University of Medical Sciences, Tehran, Iran , nnahavandi923@gmail.com
Abstract:   (491 Views)

The prevalence of nonimmunological hydrops fetalis has been reported between 1 in 1500 and 1 in 4000, with an approximate 80% mortality rate. This case-report study explains a case of hydrops fetalis, presented with generalized edema and pleural and pericardial effusion at 30 weeks of gestation with preterm birth at this age due to preterm uterine contractions. No etiology was found for hydrops and all signs resolved thoroughly after birth without treatment. After birth, the newborn was admitted to neonatal intensive care unit and discharged after 47 days in good condition. The infant was completely healthy within three months after delivery.

Full-Text [PDF 467 kb]   (276 Downloads) |   |   Full-Text (HTML)  (92 Views)  
Systematic Review: Case Report | Subject: Obstetrics and Gynecology
Received: 2020/12/12 | Accepted: 2021/04/11 | Published: 2021/06/18

1. Sohan K, Carroll SG, De La Fuente S, et al. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand. 2001 Jan 1;80(8):726-30.. [DOI:10.1034/j.1600-0412.2001.080008726.x] [PMID]
2. Bellini C, Hennekam RC. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A 2012; 158(3):597-605. [DOI:10.1002/ajmg.a.34438] [PMID]
3. Bellini C, Hennekam RC, Fulcheri E, et al. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A 2009; 2009 May;149(5):844-51 [DOI:10.1002/ajmg.a.32655] [PMID]
4. Lallemand AV, Doco-Fenzy M, Gaillard DA. Investigation of nonimmune hydrops fetalis: multidisciplinary studies are necessary for diagnosis--review of 94 cases. Pediatr Dev Pathol 1999; 1;2(5):432-9. [DOI:10.1007/s100249900146] [PMID]
5. Forouzan I. Hydrops fetalis: recent advances. Obstet Gynecol Surv 1997; 1;54(11):49-57. [DOI:10.1097/00006254-199702000-00022] [PMID]
6. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise Jr KJ, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. New Eng J Med. 2000 Jan 6;342(1):9-14. [DOI:10.1056/NEJM200001063420102] [PMID]
7. Norton ME, Chauhan SP, Dashe JS, Society for Maternal-Fetal Medicine (SMFM. Society for maternal-fetal medicine (SMFM) clinical guideline# 7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015 Feb 1;212(2):127-39. [DOI:10.1016/j.ajog.2014.12.018] [PMID]
8. Stevenson DA, Pysher TJ, Ward RM, Carey JC. Familial congenital non‐immune hydrops, chylothorax, and pulmonary lymphangiectasia. Am J Obstet Gynecol Part A. 2006 Feb 15;140(4):368-72. [DOI:10.1002/ajmg.a.31093] [PMID] [PMCID]
9. Reiterer F, Grossauer K, Morris N, Uhrig S, Resch B. Congenital pulmonary lymphangiectasis. Paediatr Respir Rev. 2014 Sep 1;15(3):275-80. [DOI:10.1016/j.prrv.2014.05.002] [PMID]
10. Carlson DE, Platt LD, Medearis AL, Horenstein J. Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol. 1990 Dec 1;163(6):1785-7. [DOI:10.1016/0002-9378(90)90749-W]
11. Castillo RA, Devoe LD, Hadi HA, Martin S, Geist D. Nonimmune hydrops fetalis: clinical experience and factors related to a poor outcome. Am J Obstet Gynecol. 1986 Oct 1;155(4):812-6.. [DOI:10.1016/S0002-9378(86)80026-6]
12. Steurer MA, Peyvandi S, Baer RJ, MacKenzie T, Li BC, Norton ME, Jelliffe-Pawlowski LL, Moon-Grady AJ. Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis—Insights from a Population-Based Dataset. J Paediatr. 2017 Aug 1;187:182-8. [DOI:10.1016/j.jpeds.2017.04.025] [PMID]
13. McCoy MC, Katz VL, Gould N, Kuller JA. Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management. Obstet Gynecol 1995; 85:578. [DOI:10.1016/0029-7844(94)00444-I]
14. Iskaros J, E Jauniaux, C Rodeck. Outcome of nonimmunological hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol 90 (1997) 321. [DOI:10.1016/S0029-7844(97)00290-1]
15. Ramon A,Lawrence D, et al. Nonimmune hydrops fetalis: Clinical experience and factors related to a poor outcome. AMJ Obstet Gynecol 1986;155:812-6. [DOI:10.1016/S0002-9378(86)80026-6]
16. Nassr AA1, Ness A, et al. Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis. Fetal Diag Ther 2018;43:123-8. [DOI:10.1159/000475990] [PMID]
17. Kim SA, Lee SM, et al. Develop an ultrasonographic severity scoring of non-immune hydrops in order to predict perinatal outcomes in women with non-immune hydrops. J Perinat 2015; 43:53
18. Swain S,AD Cameron,MB McNay,AG Howatson: Prenatal diagnosis and management of nonimmunological hydrops fetalis.Aust NZ J Obstet Gynaecol 39 (1999) 285. [DOI:10.1111/j.1479-828X.1999.tb03398.x] [PMID]
19. Xia B, Hong C,et al. Outcomes of severe primary fetal hydrothorax treated by prenatal intervention. Zhonghua Fu Chan Ke Za Zhi. 2018 Aug 25;53(8):522-7.

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.